AEGLEA BIOTHERAPEUTICS INC (AGLE) Stock Analyst Ratings
NASDAQ:AGLE - US00773J2024 - Common Stock
12.01 USD
+0.97 (+8.79%)
11.88 USD
-0.13 (-1.08%)
ChartMill assigns a Buy % Consensus number of 82% to AGLE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.85. This target is 48.63% above the current price.
AGLE was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about AGLE.
In the previous month the buy percentage consensus was at a similar level.
AGLE was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-16 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-07-25 | Stifel | Initiate | Buy |
| 2023-04-12 | LifeSci Capital | Downgrade | Outperform -> Market Perform |
| 2023-04-12 | JonesTrading | Downgrade | Buy -> Hold |
| 2023-03-03 | HC Wainwright & Co. | Maintains | Neutral |
| 2022-10-28 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2022-08-09 | Wells Fargo | Maintains | Equal-Weight |
| 2022-06-03 | Needham | Downgrade | Buy -> Hold |
| 2022-06-03 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-05-23 | Piper Sandler | Maintains | Overweight |
| 2022-05-06 | Needham | Maintains | Buy |